CSPG4 and glioblastoma: NG2-expressing GBM cells show resistance to ionizing radiation as well as rapidly recognizing DNA damage and effectuating cell cycle checkpoint signaling through the induction of ROS-scavenging enzymes, suggesting NG2 as an important prognostic factor for GBM patient survival [30].